3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.

Suppr

超能文献

作者信息

Muenter M D, Dinapoli R P, Sharpless N S, Tyce G M

出版信息

Mayo Clin Proc. 1973 Mar;48(3):173-83.

PMID:4570387

Abstract

摘要

相似文献

3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.

Mayo Clin Proc. 1973 Mar;48(3):173-83.

[Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].

Shinkei Kenkyu No Shimpo. 1971;15(1):267-85.

Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.

Trans Am Neurol Assoc. 1971;96:59-65.

3-O-Methyldopa in Parkinson's disease.帕金森病中的3 - O - 甲基多巴

Adv Neurol. 1974;5:309-15.

Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).α-甲基多巴肼（MK-486）对帕金森病左旋多巴治疗的改良作用

Trans Am Neurol Assoc. 1971;96:55-8.

Synergism of levodopa by alpha methyldopa.

Trans Am Neurol Assoc. 1971;96:231-4.

Evaluation of alpha methyl dopa and alpha methyl dopa hydrazine with L-dopa therapy.α-甲基多巴和α-甲基多巴肼与左旋多巴疗法的评估。

N Y State J Med. 1974 Jan;74(1):47-51.

[Treatment of Parkinson's syndrome with L-dopa and its methylated derivatives: 3-OMD and 4-OMD associated with a decarboxylase inhibitor. Clinical and biochemical study].[左旋多巴及其甲基化衍生物（3 - OMD和4 - OMD）联合脱羧酶抑制剂治疗帕金森综合征：临床与生化研究]

Schweiz Med Wochenschr. 1973 Oct 20;103(42):1466-74.

Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.

Mayo Clin Proc. 1972 Jun;47(6):389-95.

[Methyldopa and levodopa].

Zhonghua Yi Xue Za Zhi. 1974;7:439-41.

引用本文的文献

eToxPred: a machine learning-based approach to estimate the toxicity of drug candidates.eToxPred：一种基于机器学习的方法，用于估计候选药物的毒性。

BMC Pharmacol Toxicol. 2019 Jan 8;20(1):2. doi: 10.1186/s40360-018-0282-6.

In vivo effects of new inhibitors of catechol-O-methyl transferase.儿茶酚-O-甲基转移酶新型抑制剂的体内效应

Br J Pharmacol. 1999 Apr;126(7):1667-73. doi: 10.1038/sj.bjp.0702474.

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease.外周作用的儿茶酚-O-甲基转移酶抑制剂恩他卡朋对帕金森病患者左旋多巴急性治疗运动反应的影响。

J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):186-9. doi: 10.1136/jnnp.57.2.186.

Low catechol-O-methyltransferase activity in a Saami population.萨米人群中儿茶酚-O-甲基转移酶活性较低。

Eur J Clin Pharmacol. 1994;46(3):231-5. doi: 10.1007/BF00192554.

Catechol-O-methyltransferase inhibition by U-0521 increases striatal utilization of levodopa.

Naunyn Schmiedebergs Arch Pharmacol. 1982 Jul;320(1):34-7. doi: 10.1007/BF00499068.

Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.左旋多巴与其他药物的相互作用：在帕金森病治疗中的意义

Drugs. 1973;6(5):364-88. doi: 10.2165/00003495-197306050-00004.

Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.大鼠口服（14C）-O-甲基多巴和（14C）-L-多巴后的吸收、代谢及分布

Br J Pharmacol. 1974 Feb;50(2):259-63. doi: 10.1111/j.1476-5381.1974.tb08570.x.

Clinical pharmacokinetics of anti-parkinsonian drugs.抗帕金森病药物的临床药代动力学

Clin Pharmacokinet. 1987 Sep;13(3):141-78. doi: 10.2165/00003088-198713030-00002.

Ethnic differences in drug disposition and responsiveness.药物处置和反应性的种族差异。

Clin Pharmacokinet. 1991 May;20(5):350-73. doi: 10.2165/00003088-199120050-00002.

Influence of L-3-methoxytyrosine on monoamine synthesis in rat brain.

Naunyn Schmiedebergs Arch Pharmacol. 1975;290(4):347-56. doi: 10.1007/BF00499948.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验